Current Role of Minimal Residual Disease Assessment in the Management of Multiple Myeloma and Chronic Lymphocytic Leukemia with Drs Shaji Kumar and Philip Thompson - a podcast by Research To Practice

Dr Shaji Kumar from the Mayo Clinic in Rochester, Minnesota, and Dr Philip Thompson from the University of Texas MD Anderson Cancer Center discuss the role of minimal residual disease assessment in the management of multiple myeloma and chronic lymphocytic leukemia.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMRD21).

Further episodes of Oncology Today with Dr Neil Love

Further podcasts by Research To Practice

Website of Research To Practice